Integra LifeSciences Holdings Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 2/6
Integra LifeSciences Holdings şirketinin toplam hissedar öz sermayesi $1.5B ve toplam borcu $1.8B olup, bu da borç-öz sermaye oranını 119.1% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $4.1B ve $2.5B dir. Integra LifeSciences Holdings 'in FAVÖK'ü $220.4M faiz karşılama oranı 5.5 dur. Şirketin $296.9M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.
Anahtar bilgiler
119.1%
Borç/özkaynak oranı
US$1.83b
Borç
| Faiz karşılama oranı | 5.5x |
| Nakit | US$296.93m |
| Eşitlik | US$1.53b |
| Toplam yükümlülükler | US$2.54b |
| Toplam varlıklar | US$4.07b |
Son finansal sağlık güncellemeleri
Is Integra LifeSciences Holdings (NASDAQ:IART) A Risky Investment?
Aug 21
We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt
Feb 11Does Integra LifeSciences Holdings (NASDAQ:IART) Have A Healthy Balance Sheet?
Nov 06These 4 Measures Indicate That Integra LifeSciences Holdings (NASDAQ:IART) Is Using Debt Reasonably Well
Apr 07We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt
Jan 05Recent updates
Is Now The Time To Look At Buying Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Oct 24Why Investors Shouldn't Be Surprised By Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Low P/S
Sep 08Is Integra LifeSciences Holdings (NASDAQ:IART) A Risky Investment?
Aug 21At US$29.14, Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Worth Looking At Closely?
Jul 01Integra LifeSciences Still Underperforming As Manufacturing Issues Linger
Jun 21Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Intrinsic Value Is Potentially 40% Above Its Share Price
May 28Returns On Capital At Integra LifeSciences Holdings (NASDAQ:IART) Have Stalled
Feb 27We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt
Feb 11Is Now An Opportune Moment To Examine Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Jan 14Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Price In Tune With Earnings
Dec 31Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 46% Discount?
Dec 03Does Integra LifeSciences Holdings (NASDAQ:IART) Have A Healthy Balance Sheet?
Nov 06Integra LifeSciences Holdings (NASDAQ:IART) Hasn't Managed To Accelerate Its Returns
Oct 24Is Now An Opportune Moment To Examine Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Sep 22Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 38% Discount?
Aug 15Returns On Capital At Integra LifeSciences Holdings (NASDAQ:IART) Have Hit The Brakes
Jul 03Is There Now An Opportunity In Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Jun 19Estimating The Fair Value Of Integra LifeSciences Holdings Corporation (NASDAQ:IART)
May 05These 4 Measures Indicate That Integra LifeSciences Holdings (NASDAQ:IART) Is Using Debt Reasonably Well
Apr 07Integra LifeSciences Holdings (NASDAQ:IART) Is Experiencing Growth In Returns On Capital
Mar 26At US$52.61, Is It Time To Put Integra LifeSciences Holdings Corporation (NASDAQ:IART) On Your Watch List?
Mar 14Does Integra LifeSciences Holdings (NASDAQ:IART) Deserve A Spot On Your Watchlist?
Feb 27Calculating The Fair Value Of Integra LifeSciences Holdings Corporation (NASDAQ:IART)
Feb 02We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt
Jan 05Here's What To Make Of Integra LifeSciences Holdings' (NASDAQ:IART) Decelerating Rates Of Return
Dec 21When Should You Buy Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Dec 08Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 42% Discount?
Oct 19Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: IART 'nin kısa vadeli varlıkları ( $1.1B ) kısa vadeli yükümlülüklerini ( $328.3M ) aşıyor.
Uzun Vadeli Yükümlülükler: IART 'un kısa vadeli varlıkları ( $1.1B ) uzun vadeli yükümlülüklerini ( $2.2B ) karşılamamaktadır.
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: IART 'nin net borç/öz sermaye oranı ( 99.7% ) yüksek olarak değerlendiriliyor.
Borcun Azaltılması: IART şirketinin borç/öz sermaye oranı son 5 yılda 98.2% seviyesinden 119.1% seviyesine yükseldi.
Borç Kapsamı: IART 'nin borcu işletme nakit akışı ( 7.8% ) tarafından iyi bir şekilde karşılanmıyor.
Faiz Kapsamı: IART 'in borcuna ilişkin faiz ödemeleri EBIT ( 5.5 x kapsam) tarafından iyi bir şekilde karşılanmaktadır.